Clinical trial
Safety and Efficacy Study of Prosaptide to Treat Neuropathic Pain in…
NCT00286377 · Savient Pharmaceuticals, Industry · Terminated
Key facts
| NCT number | NCT00286377 |
|---|---|
| Title | Safety and Efficacy Study of Prosaptide to Treat Neuropathic Pain in HIV-Positive Patients |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose Ranging Study to Evaluate the Efficacy and Safety of Prosaptide Over 6 Weeks of Treatment for the Relief of Neuropathic Pain Associated With HIV-1 |
| Lead sponsor | Savient Pharmaceuticals, Industry |
| Collaborators | Neurologic AIDS Research Consortium (NARC) |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV, Peripheral Nervous System Disorders |
| Intervention type | Drug |
| Interventions | prosaptide |
| Enrollment | 350 |
| Start date | Sep 1, 2003 |
| Completion | Dec 1, 2004 |
| First posted | Feb 3, 2006 |
| Last update posted | Feb 3, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: